Henry Schein
HSIC
83.66
-1.18
-1.39%
Henry Schein
US · HSIC
#1526 by market cap
Listed 1970
83.66
-1.18
-1.39%
Live - 5344 symbols - heartbeat 368s ago
· 2026-10-08 05:15
Pre-market
83.57
-0.11%
After-hours
83.66
0.00%
- Market cap
- 9.32B
- P/E (TTM)i
- 24.39
- P/Bi
- 2.95
- EPSi
- 3.27
- Div yieldi
- 0.00%
- 52W posi
- 72%
Reader sentiment
Are you bullish or bearish on HSIC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.81, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +4.03% YoY
Margins
- Gross margin
- 31.14%
- Operating margin
- 5.75%
- Net margin
- 3.02%
Key ratios & quality
- Enterprise valuei
- 12.35B
- Altman Z-Scorei
- 2.81
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.42B | 9.99B | 10.12B | 12.40B | 12.65B | 12.34B | 12.67B | 13.18B |
| Gross profit | 2.91B | 3.09B | 2.81B | 3.67B | 3.83B | 3.86B | 4.02B | 4.11B |
| Selling & admin expenses | 2.22B | 2.36B | 2.25B | 2.63B | 2.77B | 2.96B | 3.03B | 3.08B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 693.47M | 732.97M | 567.40M | 860.00M | 878.00M | 695.00M | 731.00M | 758.00M |
| Pretax profit | 536.84M | 680.31M | 499.90M | 831.00M | 721.00M | 542.00M | 513.00M | 533.00M |
| Tax | 107.43M | 159.52M | 95.37M | 198.00M | 170.00M | 120.00M | 128.00M | 126.00M |
| Net profit | 562.13M | 719.14M | 419.42M | 660.00M | 566.00M | 436.00M | 398.00M | 419.00M |
| Basic EPS | 4 | 5 | 3 | 5 | 4 | 3 | 3 | 3 |
| Diluted EPS | 3.49 | 4.65 | 2.82 | 4.45 | 3.91 | 3.16 | 3.05 | 3.27 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.17B | 3.24B | 3.34B | 3.44B | 3.37B | 3.46B |
| Gross profit | 1.00B | 1.02B | 1.03B | 1.06B | 1.07B | 1.10B |
| Selling & admin expenses | 738.00M | 778.00M | 760.00M | 808.00M | 809.00M | 831.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 200.00M | 174.00M | 198.00M | 186.00M | 194.00M | 200.00M |
| Pretax profit | 145.00M | 121.00M | 134.00M | 133.00M | 150.00M | 137.00M |
| Tax | 35.00M | 31.00M | 28.00M | 32.00M | 38.00M | 34.00M |
| Net profit | 113.00M | 94.00M | 109.00M | 103.00M | 112.00M | 102.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.88 | 0.70 | 0.84 | 0.85 | 0.92 | 0.82 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.18B | 3.23B | 3.79B | 3.84B | 3.99B | 4.49B | 3.98B | 4.46B |
| Cash & ST investments | 56.89M | 106.10M | 421.19M | 118.00M | 117.00M | 171.00M | 122.00M | 156.00M |
| Inventory | 1.42B | 1.43B | 1.51B | 1.86B | 1.96B | 1.82B | 1.81B | 2.00B |
| Total assets | 8.50B | 7.15B | 7.77B | 8.48B | 8.61B | 10.57B | 10.22B | 11.22B |
| Total current liabilities | 3.22B | 2.04B | 2.28B | 2.31B | 2.22B | 2.68B | 2.80B | 3.23B |
| Short-term debt | 959.74M | 199.17M | 247.92M | 138.00M | 182.00M | 494.00M | 781.00M | 875.00M |
| Long-term debt | 980.34M | 622.91M | 515.77M | 811.00M | 1.04B | 1.94B | 1.83B | 2.31B |
| Total liabilities | 4,646,583,000.00 | 3,233,706,000.00 | 3,460,448,000.00 | 3,805,000,000.00 | 3,936,000,000.00 | 5,420,000,000.00 | 5,381,000,000.00 | 6,421,000,000.00 |
| Total equity | 3.85B | 3.92B | 4.31B | 4.68B | 4.67B | 5.15B | 4.84B | 4.79B |
| Retained earnings | 3.21B | 3.12B | 3.45B | 3.60B | 3.68B | 3.86B | 3.77B | 3.29B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.04B | 4.24B | 4.40B | 4.46B | 4.50B | 4.60B |
| Cash & ST investments | 127.00M | 145.00M | 136.00M | 156.00M | 138.00M | 157.00M |
| Inventory | 1.84B | 1.91B | 1.91B | 2.00B | 2.01B | 2.06B |
| Total assets | 10.48B | 10.91B | 11.10B | 11.22B | 11.30B | 11.38B |
| Total current liabilities | 2.92B | 3.01B | 3.15B | 3.23B | 3.30B | 3.49B |
| Short-term debt | 1.00B | 1.01B | 1.02B | 875.00M | 1.16B | 1.24B |
| Long-term debt | 1.97B | 2.09B | 2.15B | 2.31B | 2.33B | 2.30B |
| Total liabilities | 5,761,000,000.00 | 6,007,000,000.00 | 6,197,000,000.00 | 6,421,000,000.00 | 6,482,000,000.00 | 6,658,000,000.00 |
| Total equity | 4.72B | 4.90B | 4.90B | 4.79B | 4.82B | 4.72B |
| Retained earnings | 3.63B | 3.49B | 3.38B | 3.29B | 3.29B | 3.20B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 684.71M | 654.09M | 598.91M | 710.00M | 602.00M | 500.00M | 848.00M | 712.00M |
| Depreciation & amortization | 143.63M | 184.94M | 185.54M | 210.00M | 194.00M | 222.00M | 268.00M | 281.00M |
| Free cash flow | 613.42M | 577.87M | 550.08M | 598.00M | 474.00M | 313.00M | 661.00M | 521.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -200.00M | -163.91M | -73.79M | -401.00M | -485.00M | -250.00M | -385.00M | -600.00M |
| Ending cash balance | 56.89M | 106.10M | 421.19M | 118.00M | 117.00M | 171.00M | 122.00M | 156.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 37.00M | 120.00M | 174.00M | 381.00M | -97.00M | 242.00M |
| Depreciation & amortization | 73.00M | 76.00M | 80.00M | 52.00M | 81.00M | 84.00M |
| Free cash flow | -6.00M | 74.00M | 129.00M | 324.00M | -136.00M | 196.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -161.00M | -36.00M | -203.00M | -200.00M | -125.00M | -200.00M |
| Ending cash balance | 127.00M | 145.00M | 136.00M | 156.00M | 138.00M | 157.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.57 | 23.32 | 12.73 | 18.64 | 15.66 | 11.72 | 11.07 | 11.99 |
| ROA %i | 6.57 | 8.88 | 5.41 | 7.77 | 6.30 | 4.34 | 3.75 | 3.71 |
| ROIC %i | 12.35 | 16.18 | 10.29 | 14.40 | 11.66 | 8.30 | 7.43 | 7.53 |
| 5-year avg ROE %i | 16.88 | 18.21 | 17.39 | 17.55 | 17.78 | 16.41 | 13.96 | 13.81 |
| EBIT margin %i | 5.86 | 7.32 | 5.35 | 6.92 | 6.05 | 5.10 | 5.08 | 5.18 |
| FCF / sales %i | 4.50 | 5.79 | 5.44 | 5.08 | 4.00 | 2.54 | 5.22 | 3.95 |
| Current ratioi | 1.30 | 1.58 | 1.66 | 1.67 | 1.79 | 1.67 | 1.42 | 1.38 |
| Quick ratioi | 0.38 | 0.66 | 0.81 | 0.68 | 0.70 | 0.76 | 0.57 | 0.56 |
| Debt / assetsi | 22.82 | 13.96 | 12.90 | 14.35 | 17.39 | 25.92 | 28.09 | 30.64 |
| LT debt / equityi | 33.10 | 26.66 | 22.53 | 31.50 | 38.16 | 61.48 | 61.57 | 78.92 |
| Interest coveragei | 9.83 | 14.39 | 13.08 | 31.09 | 17.39 | 7.23 | 4.92 | 4.55 |
| Revenue CAGR (3Y) %i | -3.96 | -4.79 | 4.44 | 9.61 | 8.19 | 6.83 | 0.73 | 1.40 |
| Net income CAGR (3Y) %i | 3.81 | 11.09 | -0.21 | 5.60 | -8.17 | 1.00 | -14.82 | -9.56 |
| FCF CAGR (3Y) %i | 4.10 | 0.32 | 4.42 | -0.85 | -6.39 | -17.13 | 3.40 | 3.20 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.78 | 11.18 | 11.39 | 11.99 | 12.01 | 12.21 |
| ROA %i | 3.95 | 3.68 | 3.60 | 3.71 | 3.63 | 3.62 |
| ROIC %i | 7.63 | 7.22 | 7.21 | 7.53 | 7.18 | 7.25 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.26 | 5.18 | 5.19 | 5.18 | 5.17 | 5.24 |
| FCF / sales %i | 4.01 | 2.61 | 2.75 | 3.95 | 2.92 | 3.77 |
| Current ratioi | 1.38 | 1.41 | 1.40 | 1.38 | 1.36 | 1.32 |
| Quick ratioi | 0.58 | 0.60 | 0.60 | 0.56 | 0.56 | 0.55 |
| Debt / assetsi | 30.76 | 30.79 | 31.01 | 30.64 | 33.17 | 33.50 |
| LT debt / equityi | 67.19 | 68.19 | 71.91 | 78.92 | 79.30 | 81.56 |
| Interest coveragei | 4.90 | 4.66 | 4.60 | 4.55 | 4.49 | 4.48 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Global Distribution and Value-Added Services is the largest reported line at 84.18% of revenue, across 4 reported segments.
- The next-largest line, Global Specialty Products, is a distant second at 12.12% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Global Distribution and Value-Added Services84.18%
Global Specialty Products12.12%
Global Technology5.23%
Quote time 2026-10-08 05:15:29 · For reference only, not investment advice and not tailored to your situation.